BLFS (BioLife Solutions) Accumulated Depreciation: $-5.36 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BLFS BioLife Solutions Inc BLFS
71 GF Score
Price $29.79
GF Value $29.03
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is BioLife Solutions Accumulated Depreciation?

BioLife Solutions BLFS -0.63% 71 Accumulated Depreciation is $-5.36 Mil as of Mar. 2026. GuruFocus rates BLFS with a GF Score™ of 71/100 and a GF Value™ of $29.03 (Fairly Valued). The stock has 5 warning signs investors should review.

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

BioLife Solutions's quarterly accumulated depreciation declined from Sep. 2025 ($-4.95 Mil) to Dec. 2025 ($-4.93 Mil) but then increased from Dec. 2025 ($-4.93 Mil) to Mar. 2026 ($-5.36 Mil).

BioLife Solutions's annual accumulated depreciation declined from Dec. 2023 ($-4.26 Mil) to Dec. 2024 ($-4.16 Mil) but then increased from Dec. 2024 ($-4.16 Mil) to Dec. 2025 ($-4.93 Mil).

BioLife Solutions Accumulated Depreciation Related Terms

BioLife Solutions Accumulated Depreciation Historical Data

* Premium members only.

The historical data trend for BioLife Solutions's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioLife Solutions Accumulated Depreciation Chart

BioLife Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accumulated Depreciation
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.74 -9.17 -4.26 -4.16 -4.93

BioLife Solutions Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accumulated Depreciation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.50 -4.72 -4.95 -4.93 -5.36
BLFS
71GF Score
BioLife Solutions Inc BLFS
Accumulated Depreciation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioLife Solutions Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

What does a Accumulated Depreciation of $-5.36 Mil mean?
BioLife Solutions (BLFS) has a Accumulated Depreciation of $-5.36 Mil as of Mar. 2026. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on BioLife Solutions and its competitors.
Is BioLife Solutions' Accumulated Depreciation too high?
BioLife Solutions' current Accumulated Depreciation is $-5.36 Mil. Overall, BioLife Solutions has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BioLife Solutions' Accumulated Depreciation compare to AZTA and KMTS?
BioLife Solutions' Accumulated Depreciation of $-5.36 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accumulated Depreciation for a Medical Devices & Instruments company?
A good Accumulated Depreciation depends on the Medical Devices & Instruments industry context. However, Accumulated Depreciation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accumulated Depreciation mean?
A high Accumulated Depreciation can signal that a stock is expensive relative to its fundamentals. Accumulated depreciation is a contra-asset item that accounts for the decline in value of long-term assets. View historical data on BioLife Solutions and its competitors. BioLife Solutions's current Accumulated Depreciation is $-5.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioLife Solutions stock overvalued right now?
Based on GuruFocus' analysis, BioLife Solutions (BLFS) is currently considered Fairly Valued. The stock's GF Value™ is $29.03, compared to a current price of $29.79 — trading 2.6% above its estimated fair value. The current Accumulated Depreciation is $-5.36 Mil. BioLife Solutions' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accumulated Depreciation calculated?
Accumulated Depreciation is calculated from a company's financial statements. For BioLife Solutions (BLFS), the current Accumulated Depreciation is $-5.36 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioLife Solutions (BLFS) Overvalued in 2026?

Based on GuruFocus' analysis, BioLife Solutions stock appears to be overvalued. The current stock price of $29.79 is trading 2.6% above its estimated GF Value™ of $29.03. GuruFocus considers BioLife Solutions to be Fairly Valued.

Key valuation signals for BLFS:

  • Accumulated Depreciation: $-5.36 Mil
  • GF Value™: $29.03 vs. price of $29.79 (2.6% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the BLFS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioLife Solutions Business Description

Other Exchanges BJX1:Germany
Address 3303 Monte Villa Parkway, Suite 310, Bothell, WA, USA, 98021
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.
71GF Score

Get the complete analysis for BLFS

Accumulated Depreciation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$29.79
Price
$29.03
GF Value